1. Do all colorectal polyps require pathological examination? Aim To assess whether it is possible to omit the pathological examination of some polyps without any risk for the patient 2 studies - Retrospective study: retrospective assessment of all polyps removed from September 2003 to August 2008 within the organized gFOBT CRC screening program implemented in the Haut-Rhin (a French administrative district) 0.71 million inhabitants. All residents aged 50-74 invited to participate in a program with biennial gFOBT (Hemoccult II) (Denis B et al Gut 2007) - Prospective study: prospective assessment of all polyps removed from January to August 2008 in the endoscopy unit of Pasteur Hospital in Colmar Conclusions - Due to the risk of invasive carcinoma, all polyps > 5 mm require pathological examination. - Conversely, the pathological examination of a great number of polyps ≤ 5 mm can be safely omitted, the proportion depending on the level of risk that is considered acceptable:. All polyps ≤ 5 mm associated with a CRC or a polyp ≥ 10 mm or removed in very old patients without any risk for the patient (15 – 20% of polyps). All polyps ≤ 5 mm associated with a polyp 6 - 9 mm with the risk of a 5y surveillance interval instead of a 3y in one patient out of 175 (10% of polyps). All isolated polyps ≤ 5 mm in people with personal or family history of CRC or adenoma with the risk of a 5y surveillance interval instead of a 3y in one patient out of 44 (30% of polyps) Digestive Disease Week, Chicago, 2 June 2009 Background Médecine A, Hôpital Pasteur; Association pour le Dépistage du Cancer colorectal en Alsace (ADECA Alsace), Colmar, FRANCE Abstract Results – retrospective study Methods Percentage of correct surveillance intervals Bernard DENIS, Jacques BOTTLAENDER, Anne Marie WEISS, André PETER, Gilles BREYSACHER, Pascale CHIAPPA, Isabelle GENDRE, Philippe PERRIN Conflict of interest : none Pathological examination of removed colorectal polyps places a huge burden on pathologists and represents a non negligible cost. It is of value only if clinical management is affected eg if colorectal cancer (CRC) is detected or if the post-polypectomy surveillance interval is guided. Aim: to assess whether it is possible to omit the pathological examination of some polyps without any risk for the patient. Methods: retrospective assessment of all polyps removed from September 2003 to August 2008 within the organized gFOBT CRC screening program implemented in the Haut-Rhin and prospective assessment of all polyps removed from January to August 2008 in a hospital endoscopy unit. Results: The results of the retrospective study involving 4360 polyps are presented in the table. In the prospective study, 355 polyps were removed during 175 colonoscopic procedures. 47.4% of them were a 1st procedure and 46.5% a surveillance procedure after surgery for CRC or polypectomy. A family history of CRC was present in 13.9% of cases. 263 (74.1%) polyps were ≤ 5 mm and 54 (15.2%) were ≥ 10 mm. 90 (25.7%) polyps were non adenomatous, 76 (21.4%) advanced adenoma and 2 (0.6%) invasive carcinoma. The pathological examination was considered useful by the endoscopist for 148 (41.7%) polyps. This rate of useful examinations varied according to the polyps’ size (26.1% for polyps ≤ 5 mm, 73.7% for 6-9 mm and 92.5% for ≥ 10 mm)(p<0.001) and to the context (57.1% in case of a 1st procedure and 23.4% in case of a surveillance procedure). The pathological examination was necessary for the determination of the surveillance interval in 24.0% of patients and modified the surveillance interval proposed by the endoscopist in 8.6% of patients. It had no impact on the surveillance interval in 67.4% of patients. If isolated polyps ≤ 5 mm had not been examined in patients with either personal or family history of CRC or adenoma (37.5% of polyps in our prospective study) one patient out of 44 would have had a surveillance interval of 5 years instead of 3 years. Conclusion: Due to the risk of invasive carcinoma, all polyps > 5 mm require pathological examination. The pathological examination of diminutive polyps ≤ 5 mm either associated with a CRC or a polyp ≥ 10 mm or removed in very old patients can be omitted without any risk for the patient. They represent 13.8% of polyps in case of a diversified recruitment and 22.3% in an organized gFOBT CRC screening program. Haut-Rhin 175 colonoscopies - 68 Women – 107 Men - 64.8 y mean age - 1st colo : 47.4% - personal history of CRC or adenoma: 46.5% - 1st degree family history of CRC: 13.9% - After polypectomy, decisions regarding surgical resection and surveillance intervals are based on pathology findings of the removed specimens. - Pathological examination of all removed colorectal polyps is usually recommended. - However it places a huge burden on pathologists at a non negligible cost. - Furthermore, it is of value only if clinical management is affected eg if invasive carcinoma is detected or if the post-polypectomy surveillance interval is guided. 69 (5.1) 1290 (96.1) 1343 (33.8) ≥ 10 mm 70 (1.6)1 (0.2)0 (0)Invasive cancer n (%) 1748 (40.1)178 (30.2)280 (13.7)Advanced adenoma n (%) 3134 (71.9)483 (82.0)1361 (66.8)Adenomatous polyps n (%) 4360589 (14.8)2038 (51.3)Number n (%) all6 – 9 mm≤ 5 mmPolyps’ size Results – prospective study % patients with correct surveillance intervals % polyps ≤ 5 mm analyzed Threshold? Polyps’ size≤ 5 mm6 – 9 mm≥ 10 mmall Number n (%)261 (74.6)35 (10.0)54 (15.4)350 Adenomatous polyps n (%)180 (69.0)29 (82.9)51 (94.4)260 (74.3) Advanced adenoma n (%)22 (8.4)13 (37.1)51 (94.4)86 (24.6) Invasive cancer n (%)0 (0) 2 (3.7)2 (0.6) Endoscopist performances for the diagnosis of malignant polyp disease CRC +CRC - test CRC +25961 CRC -0294 2353355 - Sensitivity 100%- PPV 3.3% - Specificity 83.0%- NPV 100% Characteristics of polyps examined Number of polyps examined n (%) Number of patients with correct surveillance n (%) All (> 5 mm and all ≤ 5 mm )355 (100)175 (100) All except ≤ 5 mm associated with cancer or polyp ≥ 10 mm or very old age 306 (86.2)175 (100) Idem above except ≤ 5 mm associated with polyp(s) 6 – 9 mm 276 (77.7)174 (99.4) Idem above except isolated ≤ 5 mm polyps in patients with history* 143 (40.3)170 (97.1) Idem above except isolated ≤ 5 mm polyps in patients without history* (ie all polyps > 5 mm without any ≤ 5 mm ) 92 (25.9)142 (81.1) history*: personal or family history of CRC or adenoma Rate of useful pathological examinations: 41.1%